beta-blockers vs calcium channel blockers vs ACE inhibitors.
Department of Pharmacology and Clinical Pharmacology, University of Auckland, New Zealand.
N H
NH
Holford
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D017850:Economics, Pharmaceutical; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011788:Quality of Life